RecallDepth
Class II Terminated

Duloxetine Delayed-release Capsules USP 30 mg 30-count bottles, Rx Only, Manufactured by: Inventia Healthcare Private Limited Additional Ambermath M.I.D.C., Ambermath (East) 421506, INDIA, Distributed by: Cipia USA, Inc., Miami, FL 33156, NDC 69097-298-02

Company
Inventia Healthcare Private Limited
Recall Initiated
October 19, 2016
Posted
December 28, 2016
Recall Number
D-0224-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
46,848 delayed-release capsules
Firm Location
Thane, India

Reason for Recall

Failed Tablet/Capsule Specifications: Capsule shell (s) opening inside the bottle The Initial reports stated one or two capsules in a bottle count of 30s opening. First report came in June 14, 2016. Till date about 22 reports have come in from pharmacies which report two batches 130/16/001 and 130/16/002. Third batch 130/16/003 is not distributed yet, will be recalled from warehouse.

Distribution

United States

Lot / Code Info

Batch # 130/16/001, 130/16/002, 130/16/003; Exp. Date 10/17 

Other recent Class II Drug recalls